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Introduction: Identification of upper lobe emphysema is mandatory before lung
volume reduction surgery (LVRS). Here we introduce a CT-based objective model for
describing the distribution of different types of emphysema.
Methods: Fifty COPD patients were included in the study. Half had a1-antitrypsin
deficiency (a1-COPD) and the rest had smoking-induced emphysema (usual COPD). All
patients were scanned 3 times. The relative area of emphysema in each CT slice was
plotted against table position, and the cranio-caudal distribution was calculated as
the slope of the regression line.
Results: The variation in slopes within a patient was much less than the variation in
slopes between patients (Po0:0001). There was a significant difference between
slopes in the a1-COPD and the usual COPD groups (Po0:0001). In the a1-COPD group,
24/25 patients had lower lobe emphysema. In the usual COPD group, 4 patients had
upper lope predominance, 5 patients had heterogeneous distributions, and 16
patients had lower lobe predominance.
Conclusions: The majority of patients with smoking-related emphysema have a
homogeneous distribution and lower lobe predominance although not as noticeable
as in a1-antitrypsin deficiency. An objective and quantitative method for determining
the distribution of emphysema should be applied when selecting candidates for LVRS.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
45 38 23;
t.dk (T. Stavngaard).Introduction
Lung volume reduction surgery (LVRS) may kill
patients, and the indication is delicate. The
National Emphysema Treatment Trial (NETT)ed.
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Quantitative assessment of emphysema distribution 95concludes that only a very well-defined subgroup of
emphysema patients (i.e. upper lope emphysema)
will benefit from surgery; most will experience no
effect or even higher mortality with surgery
compared to conservative therapy.1 Despite the
distribution of emphysema being crucial in patient
selection, it is typically based on subjective
judgement.
Emphysema is usually classified into 3 morpholo-
gical subtypes: centrilobular emphysema (CLE),
paraseptal emphysema (PSE) and panlobular em-
physema (PLE) based on the portion of the
pulmonary lobule that is involved. These subtypes
have been described to have a characteristic
distribution within the lung.2 PLE is the predomi-
nant subtype in patients with a1-antitrypsin defi-
ciency, and is typically located in the lower lobes.3
The commonest subtype of emphysema, which is
the dominant type among cigarette smokers, is
CLE. This subtype is reported to be most frequently
distributed in the upper lung zones.2,4–6 The
imaging techniques and the definition of upper
and lower lung zones vary among investigators, as
does the description of findings. Precise evaluation
of the distribution of emphysema has greatly
improved with the introduction of computed
tomography (CT) and the description of low
attenuation areas (LAA) as the hallmark of par-
enchymal destruction in emphysema. To our knowl-
edge this was first described in 1978 by Rosenblum
et al.7 who found that patients with emphysema
have lower mean lung densities compared to
healthy individuals, and even more striking, was
the findings of large zones of extremely low density
scattered throughout the lung. Quantitation of
emphysema by CTcan be based on either subjective
(visual) or objective (computer) scoring. VisualTable 1 Patient characteristics and lung function measu
Characteristic Usual COPD
Measured % P
Sex (women/men) 18/7
Age (y) 67 (7)
Smoking (never/ex-/current) 0/0/25
Height (cm) 165 (7)
Weight (kg) 63 (11)
FEV1 (post b-2) (l) 1.19 (0.2) 52
FVC (post b-2) (l) 2.44 (0.5) 85
TLC (l) 5.86 (1.2) 108
RV (l) 3.28 (0.9) 153
DLCO (mmol/kPa/min) 3.98 (0.9) 53
KCO (mmol/kPa/min/l) 0.97 (0.3) 64
Numbers in parenthesis are standard deviations. *Range.scoring is both time-consuming and subject to
observer variability.8,9 Cederlund et al.10 have
described an interesting surgically orientated mod-
el for objective classification of emphysema het-
erogeneity using spiral CT. Their results show that
2/3 of the patients did not have clearly hetero-
geneous distribution (neither upper nor lower lobe
predominance).
Before LVRS, the distribution of emphysema must
be known. The NETT Research Group1 has shown
that surgical intervention improves survival only in
patients with predominantly upper lobe emphyse-
ma and low exercise capacity. Here, we present an
objective and quantitative method based on the
Cederlund concept for describing the distribution
of different types of emphysema; we also examine
the reproducibility of this method.Methods
Patient population
Fifty patients from outpatient clinic above 50 years
of age with COPD were included in the study.
Twenty-five patients had severe a1-antitrypsin
deficiency of PI*ZZ phenotype, verified by iso-
electric focusing, and 25 patients had normal a1-
antitrypsin. The lung disease in the latter group is
referred to as usual COPD, whereas the condition in
patients with severe a1-antitrypsin deficiency is
referred to as a1-COPD. The Ethics Committee of
the County of Copenhagen approved the study, and
all patients gave informed consent. Two patients
with a1-COPD were lifelong non-smokers and 23
were ex-smokers for at least 6 months before therements in absolute and percent predicted.
a1-COPD
redicted Measured % Predicted
13/12
59 (7)
2/23/0
171 (9)
73 (16)
(13) (29–74)* 1.26 (0.4) 44 (13) (28–72)*
(15) 3.12 (1.0) 86 (16)
(13) 7.51 (1.8) 122 (12)
(39) 4.08 (1.1) 188 (38)
(13) 3.98 (1.5) 46 (19)
(18) 0.80 (0.3) 51 (18)
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were current smokers, with a smoking history of
more than 20 pack years. None of the patients with
a1-COPD were on substitution treatment. COPD in
both groups was defined as FEV1/FVCo70% and
FEV1p80% predicted. Patient characteristics are
shown in Table 1.Pulmonary function test (PFT)
PFTs were performed according to European Re-
spiratory Society (ERS) recommendations.11,12 A
pressure-compensated flow plethysmograph (Sen-
sorMedics Vmax 229) was applied. Patients visited
the respiratory laboratory in the morning and
underwent reversibility test 15min after inhalation
of 1.0mg terbutaline (BricanylsTurbuhalers). Re-
versibilityX15% and X200ml implied exclusion
from the study. For the patients with irreversible
airflow limitation static lung volumes (i.e. total
lung capacity (TLC) and residual volume (RV)) were
determined afterwards, with the patient seated,
and with a nose clip in place, during panting with a
frequency of less than 1/s. Carbon monoxide
diffusing constant (KCO) was measured by the
single-breath technique. The diffusion capacity
was calculated as the product of KCO and the
alveolar volume, which was obtained from the
dilution of methane (CH4) during the single breath
manoeuvre. Gas volumes are reported with body
temperature and pressure saturated (BTPS) correc-
tions, and results are expressed in absolute
values and as percentage of predicted values,
calculated according to European reference
equations (Table 1).11,12Computed tomography
CT was performed at 3 visits with an interval of 2
weeks. Scans were performed as low-dose multi-
slice CT using GE equipment (GE Medical Systems,
LightSpeed QX/i). The scanner was calibrated
continuously with air and before and after the
study with a water-phantom. Volume scans of the
entire lung were acquired and no contrast medium
was used. Image acquisition was performed with
5mm collimation, rotation time 0.8 s, 30mm table
feed per rotation ðpitchx ¼ 1:5Þ, corresponding to a
total scan time of 10–12 s. The voltage across the X-
ray tube was 140 kV and tube currents was 40mA.
The field of view was 40 cm and the matrix size
512 512. The radiation dose per scan was around
1mSv. Patients were scanned during suspended
inspiration in the supine position in a caudal–cra-
nial direction (z-axis) to avoid breathing artefactsat the level of the diaphragm. Images were
reconstructed with 50% overlap using a low spatial
resolution (soft) algorithm.Image analysis
All CT scans were analysed with the Pulmo-CMS
software package (MEDIS, Medical Imaging Systems,
Leiden, The Netherlands) beta-version. The pro-
gram starts by identifying the trachea, and then
automatically detects the lung contours in over-
lapping images using a region-growing algorithm to
separate lung tissue from the thoracic wall and
mediastinum. The threshold chosen for soft tis-
sue–lung interface was 380 HU. Afterwards, a
frequency distribution of the pixel attenuation
values of the total lung was generated. From this
histogram total lung weight and volume were
calculated in each slice of the lung. In addition,
the relative area of emphysema was calculated.
The relative area is defined as the percentage of
voxels below 910HU, divided by the total area
of the lung in each slice to obtain the percentage of
emphysematous lung. There is good correlation
between pathologic quantitation of emphysema
and relative area using a threshold of 910HU
(RA-910).8Quantitative parameters
We aimed to investigate the distribution/hetero-
geneity of emphysema throughout the lung. For this
purpose we modified the technique described by
Cederlund et al.,10 where the distribution is
indicated by a slope for each CT scan. The slope
was calculated as follows: slices with more than
15ml of lung volume were included, and to avoid
partial volume effects from the diaphragm, the
lowest 15% of slices were excluded.
For each of the remaining slices of the CT scan,
RA-910 was plotted against table-position (Fig. 1),
and assuming a linear relationship, the slope was
determined by a least-square fit, where each point
was weighted by the number of pixels of the slice
represented by the point. The slopes were stan-
dardized as the predicted (from the regression
analysis) difference in the amount of emphysema of
the lowest and upper slices by multiplying the slope
per slice by the number of slices. Thus, the slope is
positive if emphysema is most pronounced in the
caudal part of the lung, and negative if it is most
pronounced in the cranial part of the lung. The
slope estimate describes the overall increase/
decrease in emphysema from the most cranial part
to the most caudal one.
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Figure 1 RA-910 profiles are shown for two representative patients, one with a-COPD (left) and one with usual COPD
(right). The table position in cranio-caudal direction is indicated on the x-axis. Slices with lung volume less than 15ml
and the inferior 15% of the slices are not shown. On the y-axis RA-910 for each slice are plotted, and the weighted
regression line is drawn.
Table 2 Results from the RA-910 analysis.
Usual COPD a1-COPD
RA-910 (%) 18.4 (11.9)* 40.7 (14.6)*
RA-910o10% (number of patients) 5 1
Slope RA-910: SD within patients** 3 Po0:0001 3.5 Po0:0001
Slope RA-910: SD between patients** 42 42
Mean slope RA-910 9.6 (24.1)* 45.1 (23.7)*
**One-way variance analyses.
*Numbers in parenthesis are standard deviations (SD).
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One-sided analysis of variance was used to evaluate
the variation in slopes within and between patients
in the two groups. Two-sample t-test for the means
of slopes was used to evaluate the difference
between the usual COPD and a-COPD. All analyses
were performed using the SAS software package
(version 2001 release 8.2; SAS Institute Inc., Cary,
NC, USA).Results
Twenty-four patients in both the usual COPD group
and the a1-COPD group were scanned 3 times. One
patient from each group was scanned only twice.
The total amount of emphysema in the 2 groups is
listed in Table 2. The distribution of emphysema
and the reproducibility of the RA-910 slopes are
illustrated in Fig. 2. The variation in slopes within a
patient was much less than the variation in slopes
between patients (F-test: Po0:0001). There was asignificant difference between slopes in the a1-
COPD group (mean 45.10 (SD 23.70)) as compared to
the usual COPD group (mean 9.63 (SD 24.11))
Po0:0001.
In the a1-COPD group 1 patient had a negative
slope, the rest were positive. In the usual COPD
group, 4 patients had negative slopes, 5 patients
had slopes close to 0, and 16 patients had positive
slopes (Fig. 2). In Fig. 3 the RA-910 slopes are
plotted against the severity of emphysema in the
patients.Discussion
In a group of patients with smoking-induced COPD,
we found that only 4 of 25 patients had upper lobe
predominance of emphysema, whereas 21 had
either homogeneously distributed emphysema/
mild emphysema (slopes close to 0) or even lower
lobe predominance (Fig. 2). This is contrary to the
statement, found in most textbooks, that the
main emphysema subtype among smokers: CLE is
ARTICLE IN PRESS
Figure 3 The cranio-caudal distribution of emphysema (y-axis) against severity of emphysema (x-axis) for patients with
usual COPD (filled squares) and patients with a1-antitrypsin deficiency is shown.
Figure 2 The distribution of emphysema along the vertical (x) axis for usual (filled squares) and a1-COPD (circles) is
shown. The mean slopes (i.e. the overall increase/decrease in emphysema from the most cranial part to the most
caudal one) for 3 analyses in each patient are plotted, and 1 SD is shown. The patients in the two groups are ordered by
increasing slopes.
T. Stavngaard et al.98primarily located in the upper lung zones.2,4,13,14
However, most of the references for this statement
were based on subjective scoring of the extent of
emphysema. Precise evaluation of the distribution
of emphysema has greatly improved since theintroduction of CT, but no consensus exists, either
on how various subtypes of emphysema should be
discriminated or on how the distribution of emphy-
sematous lesions should be quantified, and studies
have shown differences between visual grading and
ARTICLE IN PRESS
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on objective and quantitative CT measures have
been reported and results from these studies
indicate, as in the present study, homogeneous
distributed or lower lobe distribution of emphyse-
ma in smokers.10,15
The present study has limitations. Although we
are not aware of any sampling bias, the selection of
patient from the outpatient clinic was not per-
formed in a consecutive way. Furthermore, the
sample size is small and our results may not be
representative for the much larger group of COPD
patients in the general population. Also, the extent
of emphysema may be of importance, as the
disease progresses, more of the lung becomes
emphysematous, and the predominant location of
emphysema may change and grow indistinct. In this
study emphysema was less extensive in patients
with usual COPD than in patients with a1-antitryp-
sin deficiency (Table 2 and Fig. 3). However, as
shown in Fig. 3 the three patients with a1-
antitrypsin deficiency who had less than 20%
emphysema still had a higher slope than patients
with usual COPD and less than 20% emphysema.
Our method clearly discriminated between the
two groups of patients (Table 2 and Fig. 2), and
confirmed objectively the lower lobe predilection
of PLE associated with a1-antitrypsin defi-
ciency.16,17 Twenty-four of 25 patients with PLE
showed mainly lower lobe involvement. The meth-
od also showed a good reproducibility (Table 2 and
Fig. 2).
Our results and objective method may be
relevant for patients considered for lung volume
reduction surgery (LVRS). The NETT dealing with
LVRS in patients with severe emphysema has shown
that the anatomical distribution of emphysema has
major impact on the outcome of the surgical
procedure. It has been concluded that LVRS
improves survival and exercise capacity only in a
subgroup of patients with predominant upper lobe
emphysema and low exercise capacity.1 It also
states that the cost-effectiveness ratio for surgery
as compared to medical therapy was relatively
unfavourable, and stressed the importance of
patient selection.18 The emphysema distribution
classification in the NETT was based upon subjec-
tive scoring from different radiologists. With an
objective method of mapping the distribution of
emphysema, it may be possible to exclude more
consistently patient with non-upper lobe predomi-
nance, which may increase the success rate of
LVRS. Patients with truly upper lobe emphysema
must be identified before surgery, and we believe
this should include an objective and quantitative
method such as the one presented in this study.In conclusion, the objective method proposed in
this study is able to discriminate between the
groups of patients with a1-COPD and usual COPD.
The majority of patients with PLE due to a1-COPD
had lower lobe predominance of their emphysema
(24/25 patients). In the group of usual COPD, only
4/25 patients showed upper lobe predominance,
whereas the rest showed a homogeneous dis-
tribution or even a tendency to lower lobe
predominance.References
1. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R,
Ries A, et al. A randomized trial comparing lung-volume-
reduction surgery with medical therapy for severe emphy-
sema. N Engl J Med 2003;348(21):2059–73.
2. Webb WR, Mu¨ller NL, Naidich DP. High-resolution CT of the
lung, 3rd ed. Lippincott Williams & Wilkins; 2001.
3. Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta
Med Scand Suppl 1965;432:1–85.
4. Thurlbeck WM, Muller NL. Emphysema: definition, imaging,
and quantification. Am J Roentgenol 1994;163(5):1017–25.
5. Gurney JW, Jones KK, Robbins RA, Gossman GL, Nelson KJ,
Daughton D, et al. Regional distribution of emphysema:
correlation of high-resolution CT with pulmonary function
tests in unselected smokers. Radiology 1992;183(2):457–63.
6. Martelli NA, Hutchison DC, Barter CE. Radiological distribu-
tion of pulmonary emphysema. Clinical and physiological
features of patients with emphysema of upper or lower
zones of lungs. Thorax 1974;29(1):81–9.
7. Rosenblum LJ, Mauceri RA, Wellenstein DE, Bassano DA,
Cohen WN, Heitzman ER. Computed tomography of the lung.
Radiology 1978;129(2):521–4.
8. Muller NL, Staples CA, Miller RR, Abboud RT.
’ ’
Density
mask’’. An objective method to quantitate emphysema using
computed tomography. Chest 1988;94(4):782–7.
9. Madani A, Keyzer C, Gevenois PA. Quantitative computed
tomography assessment of lung structure and function in
pulmonary emphysema. Eur Respir J 2001;18(4):720–30.
10. Cederlund K, Tylen U, Jorfeldt L, Aspelin P. Classification of
emphysema in candidates for lung volume reduction
surgery: a new objective and surgically oriented model for
describing CT severity and heterogeneity. Chest
2002;122(2):590–6.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R,
Yernault JC. Lung volumes and forced ventilatory flows.
Report Working Party Standardization of Lung Function
Tests, European Community for Steel and Coal. Official
Statement of the European Respiratory Society. Eur Respir J
Suppl 1993;16:5–40.
12. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC.
Standardization of the measurement of transfer factor
(diffusing capacity). Report Working Party Standardization
of Lung Function Tests, European Community for Steel and
Coal. Official Statement of the European Respiratory
Society. Eur Respir J Suppl 1993;16:41–52.
13. Rubin E, Faber JL. The respiratory system. In: Rubin E, Faber
JL, editors. Pathology. Philadelphia: J.B. Lippincott Com-
pany; 1994. p. 557–617.
14. Murray J, Nadel J. Textbook of respiratory medicine, 3rd ed.
Philadelphia, PA: W.B. Saunders Company; 2000.
ARTICLE IN PRESS
T. Stavngaard et al.10015. Sashidhar K, Gulati M, Gupta D, Monga S, Suri S. Emphysema
in heavy smokers with normal chest radiography. Detection
and quantification by HCRT. Acta Radiol 2002;43(1):60–5.
16. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG.
Clinical features and history of the destructive lung disease
associated with alpha-1-antitrypsin deficiency of adults with
pulmonary symptoms. Am Rev Respir Dis 1988;138(2):327–36.17. Guest PJ, Hansell DM. High resolution computed tomography
(HRCT) in emphysema associated with alpha-1-antitrypsin
deficiency. Clin Radiol 1992;45(4):260–6.
18. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood
DE. Cost effectiveness of lung-volume-reduction surgery for
patients with severe emphysema. N Engl J Med 2003;
348(21):2092–102.
